Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -38.23% vs 32.06% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -28.47% vs 1.41% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "200.00",
          "val2": "323.80",
          "chgp": "-38.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.10",
          "val2": "32.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.80",
          "chgp": "-25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "20.60",
          "val2": "28.80",
          "chgp": "-28.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "109.10%",
          "val2": "71.50%",
          "chgp": "3.76%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 17.20% vs -0.72% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -19.93% vs 7.53% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,133.10",
          "val2": "966.80",
          "chgp": "17.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "123.80",
          "val2": "139.60",
          "chgp": "-11.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "1.60",
          "chgp": "43.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "96.00",
          "val2": "119.90",
          "chgp": "-19.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "76.30%",
          "val2": "109.80%",
          "chgp": "-3.35%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY

Jun'26

Jun'25

Change(%)

Net Sales

200.00

323.80

-38.23%

Operating Profit (PBDIT) excl Other Income

32.10

32.10

Interest

0.60

0.80

-25.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

20.60

28.80

-28.47%

Operating Profit Margin (Excl OI)

109.10%

71.50%

3.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2026 is -38.23% vs 32.06% in Jun 2025

Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is -28.47% vs 1.41% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,133.10

966.80

17.20%

Operating Profit (PBDIT) excl Other Income

123.80

139.60

-11.32%

Interest

2.30

1.60

43.75%

Exceptional Items

0.00

0.00

Consolidate Net Profit

96.00

119.90

-19.93%

Operating Profit Margin (Excl OI)

76.30%

109.80%

-3.35%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 17.20% vs -0.72% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -19.93% vs 7.53% in Dec 2024

All Annual Results